All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Nutrition, Vitamin C | NCIT_C15928 | [Role of Vitamin C, its precursons, and its analogs in cancer causation or prevention and in general health.] |
| Nutrition, Vitamin E | NCIT_C15929 | [Role of Vitamin E (alpha-tocopherol), its precursons, and its analogs in cancer causation or prevention and in general health.] |
| Clinical Management | NCIT_C15931 | |
| Effectiveness of Interventions | NCIT_C15932 | |
| Health Research Service | NCIT_C15933 | |
| Risk Factor Service | NCIT_C15934 | |
| Surveillance Modeling | NCIT_C15935 | |
| Modeling | NCIT_C16063 | [The use of statistical analysis, computer analysis, or model organisms to predict outcomes of research. (doegenomes.org)] |
| Validity of Self Report | NCIT_C15936 | |
| Community Practice | NCIT_C15937 | [Healthcare services rendered within a given population or segment of a society.] |
| Cooperative Family Registry | NCIT_C15938 | [A comprehensive, collaborative infrastructure, linked to an informatics structure, to help speed the genetic and epidemiologic study of heritable cancers. Twelve participating institutions are located in the United States, Canada, and Australia.] |
| Cancer Chromosome Aberration Project | NCIT_C15939 | [NCI Initiative to integrate the cytogenetic and physical maps of the human genome, generate a repository of BAC clones arrayed across the genetic and physical map, and to develop a publicly available database displaying this clone repository and providing a platform for correlation with other databases of chromosomal aberrations, as well as clinical and histopathological information.] |
| Genetic Annotation Index | NCIT_C15940 | [A listing of genetic variations in genes important to cancer] |
| Interdisciplinary Studies in the Genetic Epidemiology of Cancer | NCIT_C15941 | [Collaborative and interdisciplinary genetic epidemiology investigations designed to identify and evaluate the interactions of genetic and epidemiologic risk factors leading to cancer susceptibility in individuals, families and populations, and factors influencing the rate of increase with age in cancer susceptibility. Emphasis on multi-site, cooperative research by multi- disciplinary teams of investigators wishing to collaborate within the common theme of the genetic epidemiology of cancer. Particular emphasis is placed on encouraging interdisciplinary, population-based research focusing on the etiologic mechanisms underlying the interaction of genetic and epidemiologic risk factors for cancer susceptibility. The effect on cancer susceptibility of age-related changes over the lifespan, and the genetic factors leading to older age at onset of cancer are also of interest.] |
| Basic Behavioral Studies in Cancer-Related Behaviors | NCIT_C15942 | [Basic behavioral studies designed to strengthen the understanding of the determinants and processes that influence cancer-related risk behaviors.] |
| Directory of Cancer Genetics Providers | NCIT_C15943 | |
| Mouse Cancer Genome Anatomy Project | NCIT_C15944 | [Similar to the human CGAP. The overall goals of the m-CGAP are: a comparative assessment of mouse cancer stages with those of cognate human cancers, both to validate the mouse models and to promote crossfeeding in the identification of genes that characterize those cancers; the discovery of new genes and gene pathways involved in the stages of carcinogenesis.] |
| Small Animal Imaging Resource Programs | NCIT_C15945 | [A program to improve access to researchers testing new approaches to diagnosis, treatment and prevention in animal models of cancer. Focus will be on functional, quantitative imaging. (Bypass Budget)] |
| Diagnostic Imaging Program | NCIT_C16046 | [(1) Plans and coordinates the development; (2) coordinates the clinical testing of new approaches in academia, industry, or in other parts of the federal government; (3) coordinates the development targeted to specific biochemical or physiological processes in cancer cells for better biologic insight into the physiology of human tumors; (4) encourages industrial commitment to the development and ultimate clinical testing relevant to cancer; (5) coordinates activities with other programs of the Institute, other federal agencies, and outside organizations; (6) coordinates the activities of the branches within the Program for productive interactions and effective technology transfer; and (7) assesses the activities of the Program and advises the Division Director regarding scientific opportunities for the development of new approaches to the diagnosis and treatment of cancer.] |
| Development and Application of Imaging in Therapeutic Studies | NCIT_C15946 | [This initiative will encourage applications that apply imaging technologies in the assessment of investigational cancer therapeutic agents. The proposed research projects will focus on the development and application of non-invasive tools for the functional or quantitative assessment of biochemical, genetic, or pharmacologic activity of specific therapeutic agents, or the defined biochemical pathway(s) in which they act. (from an RFA description)] |